1048
M. Yan, Z.-G. Luo, X.-F. Zhu and D.-Q. Shi
Vol 45
temperature until the reaction finished (monitored by TLC) and
the mixture was concentrated under vacuum. The residue was
washed with brine, extracted with CHCl3 (3ꢀ30 mL) and dried
over anhydrous MgSO4, respectively. The filtrate was evapo-
rated and the residue was purified by column chromatography
on silica gel (CH2Cl2:CH3OH (v/v) =15~10:1), giving the
corresponding imidazolines 3a-3b in 69-87% yields.
purified by flash column chromatography on silica gel
(CH2Cl2:CH3OH (v/v) =15~10:1), giving the corresponding 2 in
66~86% yields.
1,3-Bis-(6-chloropyridin-3-ylmethyl)-2-(bis-cyanomethyl-
idene)imidazolidine (2a). White crystals, mp 187-188º; ir: CN
1
2202, 2171, CO 1710 cm-1; H nmr: ꢀ 3.67 (s, 4H, CH2CH2),
4.84 (s, 4H, CH2N), 7.42 (d, J = 7.6 Hz, 2H, H-C(5) of pyridine),
7.74 (d, J = 6.8 Hz, 2H, H-C(4) of pyridine), 8.36 (s, 2H, H-
C(2) of pyridine); ms: m/z 386 (36), 384 (M+, 66), 258 (62), 232
(22), 126 (100), 98 (21), 90 (26), 62 (10). Anal. Calcd. for
C18H14Cl2N6: C, 56.12; H, 3.66; N, 21.81. Found: C, 55.96; H,
3.58; N, 21.57.
(E) 1-(pyridin-3-ylmethyl)-2-[(ethoxycarbonyl)(cyano)-
methylidene]-3H-imidazoline (3a). white crystals, mp 126-
1
128º; ir: N-H 3250, CN 2195, CO 1665 cm-1; H nmr: ꢀ 1.32 (t,
3H, CH3), 3.55-3.57 (m, 2H, CH2CH2), 3.63-3.65 (m, 2H,
CH2CH2), 4.21 (q, 2H, CH2CH3), 5.00 (s, 2H, NCH2), 7.38 (s,
1H, H-C(2) of pyridine), 7.81 (d, 1H, H-C(5) of pyridine), 8.58
(d, J = 7.6Hz, 1H, H-C(4) of pyridine), 8.75(s, 1H, H-C(6) of
pyridine), 8.75 (s, 1H, NH); ms: m/z 274 (13), 272 (M+, 77), 227
(49), 197 (62), 159 (76), 133 (28), 92 (100), 65 (28). Anal.
Calcd. for C14H16N4O2: C, 61.75; H, 5.92; N, 20.58. Found: C,
61.67; H, 5.81; N, 20.69.
(E) 1-(2-Chlorothiazol-5-ylmethyl)-2-[(ethoxycarbonyl)-
(cyano)methylidene]-3H-imidazoline (3b). white crystals, mp
119-121º; ir: N-H 3302, CN 2180, CO 1680 cm-1; 1H nmr: ꢀ 1.30
(t, 3H, CH3), 3.61-3.72 (m, 2H, CH2CH2), 3.74-3.81 (m, 2H,
CH2CH2), 4.16-4.23 (m, 2H, CH2CH3), 5.06 (s, 2H, NCH2), 7.53
(s, 1H, thiazole-H), 8.72 (s, 1H, NH). Anal. Calcd. for
C12H13ClN4O2S: C, 46.08; H, 4.19; N, 17.91. Found: C, 45.91;
H, 4.08; N, 17.84.
Preparation of 1-(6-chloropyridin-3-ylmethyl)-3-(2-chloro-
thiazol-5-ylmethyl)-2-[(ethoxycarbonyl)(cyano)methylidene]-
imidazolidine (4). The solution of 3b (0.012 mol) in DMF
(5mL) was added dropwise to a mixture of NaH (0.012 mol) and
anhydrous DMF (10 mL) under N2 at 0~5 °C. After no more
bubble was evolved, the solution of 2-chloro-5-(chloromethyl)-
pyridine (0.01 mol) in DMF (5mL) was added dropwise to the
above solution while cooling in an ice-bath. After the addition
complete, the mixture was stirred at room temperature until the
reaction finished (monitored by TLC). The mixture was
concentrated under vacuum, washed with brine, extracted with
CHCl3 (3ꢀ30 mL) and dried over anhydrous MgSO4,
respectively. The filtrate was evaporated and the residue was
purified by column chromatography on silica gel (petroleum
1,3-Bis-(2-chlorothiazol-5-ylmethyl)-2-(bis-cyanomethylid-
ene)imidazolidine (2b). White crystals, mp 197-198º; ir: CN
1
2190, 2175 cm-1; H nmr: ꢀ 3.62 (s, 4H, CH2CH2), 4.89 (s, 4H,
2CH2N), 7.73 (s, 2H, thiazole-H). ms: m/z 398 (28), 396 (M+,
73), 237(65), 211 (34), 132 (100), 98 (21), 62 (15). Anal. Calcd.
for C14H10Cl2N6S2: C, 42.32; H, 2.54; N, 21.15. Found: C, 42.28;
H, 2.61; N, 21.37.
1,3-Bis-(6-chloropyridin-3-ylmethyl)-2-[(cyano)(ethoxycar-
bonyl)methylidene]imidazolidine (2c). White crystals, mp
1
172-174º; ir: CN 2182, CO 1692, 1678, 1540 cm-1; H nmr: ꢀ
1.29 (t, 3H, CH3), 3.49 (s, 4H, CH2CH2), 4.17 (q, 2H, CH2CH3),
4.67 (s, 4H, CH2N), 7.39 (d, J = 8.0 Hz, 2H, H-C(5) of pyridine),
7.82 (d, J = 6.8 Hz, 2H, H-C(4) of pyridine), 8.36 (s, 2H, H-
C(2) of pyridine). Anal. Calcd. for C20H19Cl2N5O2: C, 55.57; H,
4.43; N, 16.20. Found: C, 55.76; H, 4.18; N, 15.97.
1,3-Bis-(2-chlorothiazol-5-ylmethyl)-2-[(cyano)(ethoxycar-
bonyl)methylidene] imidazolidine (2d). yellow viscous solid;
ir: CN 2190, CO 1725 cm-1; 1H nmr: ꢀ 1.18 (t, 3H, CH3), 3.58 (s,
4H, CH2CH2), 4.06 (q, 2H, CH2CH3), 4.74 (s, 4H, CH2N), 7.70
(s, 2H, thiazole-H); ms: m/z 445 (30), 443 (M+, 72), 284 (64),
258 (22), 211(18), 132 (100), 109 (10). Anal. Calcd. for
C16H15Cl2N5O2S2: C, 43.25; H, 3.40; N, 15.76. Found: C, 43.48;
H, 3.31; N, 15.64.
1,3-Bis-(6-chloropyridin-3-ylmethyl)-2-[(cyano)(O,O-dieth-
ylphosphonyl)methylidene]imidazolidine (2e). white crystals,
1
mp 117-118º; ir: CN 2164, P=O 1248, P-O-C 1103 cm-1; H
nmr: ꢀ 1.33 (t, 6H, CH2CH3), 3.43 (s, 4H, CH2CH2), 4.11 (q, 4H,
CH2CH3), 4.81 (s, 4H, CH2N), 7.37 (d, J = 7.6 Hz, 2H, H-C(5)
of pyridine), 7.92 (d, J = 6.8 Hz, 2H, H-C(4) of pyridine), 8.34
(s, 2H, H-C(2) of pyridine). Anal. Calcd. for C21H24Cl2N5O3P: C,
50.82; H, 4.87; N, 14.11. Found: C, 50.69; H, 4.80; N, 13.99.
1,3-Bis-(6-chloropyridin-3-ylmethyl)-2-[(ethoxycarbonyl)-
(O,O-diethylphosphonyl)methylidene]imidazolidine (2f).
white crystals, mp 143-145º; ir: CO 1720, P=O 1277, P-O-C)
1220, 1107 cm-1; 1H nmr: ꢀ 1.20-1.25 (m, 9H, CH3), 3.47 (s, 4H,
CH2CH2), 4.05-4.13 (m, 6H, CH2CH3), 4.70 (s, 4H, CH2N), 7.36
(d, J = 7.6 Hz, 2H, H-C(5) of pyridine), 7.92 (d, J = 7.2 Hz, 2H,
H-C(4) of pyridine), 8.32 (s, 2H, H-C(2) of pyridine). Anal.
Calcd. for C23H29Cl2N4O5P: C, 50.84; H, 5.38; N, 10.31. Found:
C, 50.96; H, 5.63; N, 10.25.
Preparation of (E) 1-substitued-2-[(ethoxycarbonyl)-
(cyano)methylidene]-3H-imidazolines 3. To a mixture of NaH
(0.012 mol) and unhydrous DMF (10 mL) in 50 mL three-
necked flask, was added dropwise the solution of 2-
substitutedmethylidene imidazolidine (2) (0.012 mol) in DMF (5
mL) under N2 at 0-5 °C. After no more bubble was evolved, the
solution of 2-chloro-5-(chloromethyl)-thiazole or 3-(chloro-
methyl)-pyridine (0.01 mol) in DMF (5 mL) was added
dropwise to the above solution while cooling in an ice-bath.
After the addition complete, the mixture was stirred at room
ether:acetone (v/v)
asymmetrical disubstituted imidazoline 4 in 70% yield. white
=
2:1), giving the corresponding
1
viscous solid; ir: CN 2190, CO 1728 cm-1; H nmr: ꢀ 1.26-1.34
(m, 3H, CH3), 3.45-3.53 (m, 2H, CH2CH2), 3.55-3.60 (m, 2H,
CH2CH2), 4.17-4.23 (m, 2H, CH2CH3), 4.68 (s, 2H, NCH2), 4.76
(s, 2H, NCH2), 7.38 (d, J = 8.0 Hz, 1H, H-C(5) of pyridine); 7.49
(s, 1H, H-C(2) of pyridine); 7.80 (d, J = 7.2 Hz, 1H, H-C(3) of
pyridine), 8.32 (s, 1H, thiazole-H); ms: m/z 440 (16), 438 (M+,
38), 312 (24), 306(18), 126 (100), 90 (70). Anal. Calcd. for
C18H17Cl2N5O2S: C, 49.32; H, 3.91; N, 15.98. Found: C, 49.27;
H, 3.76; N, 15.75.
Fungicidal activity testing. The fungicidal activity
measurement method was adapted from the one described by
Molina Torres et al. [20]. The synthesized target compounds were
dissolved in 0.5-1.0 mL of DMF to the concentration of 500 mg/L.
The solutions (1 mL) were mixed rapidly with thawed potato
glucose agar culture medium (9 mL) under 50 ºC. The mixtures
were poured into Petri dishes. After the dished were cooled, the
solidified plates were incubated with 4 mm mycelium disk,
inverted, and incubated at 28 ºC for 48 h. Distilled water was used
as the blank control. Three replicates of each test were carried out.
The mycelial elongation radius (mm) of fungi settlements was